Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms.
- 2010-09-26
- RCT · n = 26
- Archives of gynecology and obstetrics 284(2)
- Phongthorn Virojchaiwong
- Visut Suvithayasiri
- Arunporn Itharat
- PubMed: 20872225
- DOI: 10.1007/s00404-010-1689-5
- High evidence
- Clinical
After 3 and 6 months of treatment, scores were 17.92 ± 10.40 versus 15.35 ± 8.44 (p = 0.332) and 14.08 ± 10.30 versus 12.46 ± 6.38 (p = 0.500), respectively.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 50 mg/day